A double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of thymopentin as an adjunctive treatment in atopic dermatitis - Concepedia

Concepedia

Publication | Closed Access

A double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of thymopentin as an adjunctive treatment in atopic dermatitis

35

Citations

28

References

1994

Year

Matthew J. Stiller, Jerome L. Shupack, Clare Kenny, L. Jondreau, David E. Cohen, Nicholas A. Soter

Journal of the American Academy of Dermatology

Atopic DermatitisClinical TrialsClinical DermatologyAdjunctive TreatmentDermatologyImmunotherapyMedicinePlacebo-controlled Clinical Trial

References

	Year	Citations

Page 1